Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-19T15:45:47.130Z Has data issue: false hasContentIssue false
  • English
  • Français

Chronic Disease and Other Determinants in Deaths Due to COVID-19 From a Health Protection and Promotion Perspective: A Retrospective Analysis

Published online by Cambridge University Press:  05 January 2023

Filiz Özkan Open the ORCID record for Filiz Özkan [Opens in a new window] ,
Mustafa Öztürk ,
Ömer Ödek  and
Mümin Savaş
Filiz Özkan*
Affiliation:
Erciyes University Faculty of Health Sciences, Talas Turkey
Mustafa Öztürk
Affiliation:
Kayseri City Training and Research Hospital, Turkey
Ömer Ödek
Affiliation:
Kayseri City Training and Research Hospital, Turkey
Mümin Savaş
Affiliation:
Adiyaman University, Adiyaman, Turkey
*
Corresponding author: Filiz Özkan, Email: filizozkan@erciyes.edu.tr
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To examine the age, gender, and chronic disease status of patients who died due to coronavirus disease 2019 (COVID-19) during the pandemic process and the effects of these diseases on their deaths.

Methods:

It was a retrospective retrospective analysis with 2715 patients. The statistics of the patients who met the research criteria were evaluated from the hospital database. Patients were evaluated in terms of age, gender, length of hospital stay, presence of chronic disease, and Modified Comorbidity Index Scores.

Results:

It was determined that the Modified Charlson Comorbidity Index (MCCI) score mean of the patients was 4.74 ± 2.07 and MCCI scores of 56.9% were serious. There was a statistically significant difference in the length of hospital stay according to the number of diseases the patient had, age, and MCCI score. It was determined that there was a statistically significant, negative and high-level correlation between MCCI score and the length of hospital stay (r = −0.075: P = 0.001).

Conclusions:

Age, comorbidity score, and the number of comorbidities were found to affect the length of hospital stay, ie death. For this reason, it is recommended to use comorbidity indices in health protection and development studies, in the field, as well as in the clinics.

Keywords

COVID-19comorbidity indexchronic disease
Type
Original Research
Information
Disaster Medicine and Public Health Preparedness , Volume 17 , 2023 , e325
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

WHO. WHO Coronavirus (COVID-19) Dashboard. 2021. Accessed February 11, 2021. https://covid19.who.int/.Google Scholar
Aslaner, H, Aslaner, HA, Gökçek, MB, et al. The effect of chronic diseases, age and gender on morbidity and mortality of COVID-19 ınfection. Iran J Public Health. 2021;50(4):721-727.Google ScholarPubMed
Centers for Disease Control and Prevention. People with certain medical conditions. 2021. Accessed April 8, 2021. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.Google Scholar
Rosenthal, N, Cao, Z, Gundrum, J, et al. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2021;3(12):e2029058.CrossRefGoogle Scholar
Shi, S, Qin, M, Shen, B, et al. Association of cardiac ınjury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-810.CrossRefGoogle ScholarPubMed
Williamson, EJ, Walker, AJ, Bhaskaran, K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-436.CrossRefGoogle ScholarPubMed
Yates, T, Zaccardi, F, Islam, N, et al. Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort. BMC Infect Dis. 2021;21(1):717.CrossRefGoogle ScholarPubMed
Yang, X, Yu, Y, Xu, J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481.CrossRefGoogle Scholar
Zhou, F, Yu, T, Du, R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.CrossRefGoogle ScholarPubMed
Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.CrossRefGoogle ScholarPubMed
Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.CrossRefGoogle ScholarPubMed
Qian, G-Q, Yang, N-B, Ding, F, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM. 2020;113(7):474-481.CrossRefGoogle Scholar
Xu, X, Yu, C, Qu, J, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020;47(5):1275-1280.CrossRefGoogle ScholarPubMed
Yang, J, Zheng, Y, Gou, X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and metaanalysis. Int J Infect Dis. 2020;94:91-95.CrossRefGoogle ScholarPubMed
Zhang, J-J, Dong, X, Cao, Y-Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-1741.CrossRefGoogle ScholarPubMed
Xu, Y-H, Dong, J-H, An, W-M, et al. Clinical and computed tomographicimaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80(4):394-400.Google Scholar
Wang, Z, Yang, B, Li, Q, et al. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020. doı: 10.1093/cid/ciaa272 Google Scholar
Li, B, Yang, J, Zhao, F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538.CrossRefGoogle ScholarPubMed
Hacker, KA, Briss, PA, Richardson, L, et al. COVID-19 and chronic disease: the ımpact now and in the future. Prev Chronic Dis. 2021;18:E62. doi: 10.5888/pcd18.210086 CrossRefGoogle ScholarPubMed
Quan, H, Li, B, Couris, CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676-682.Google ScholarPubMed
Imam, Z, Odish, F, Gill, I, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. 2020;288:469-476.CrossRefGoogle Scholar
Charlson, ME, Pompei, P, Ales, KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.CrossRefGoogle ScholarPubMed
Extermann, M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35(3):181-200.CrossRefGoogle ScholarPubMed
Biswas, M, Rahaman, S, Biswas, TK, et al. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2021;64:36-47. doı:10.1159/000512592 CrossRefGoogle Scholar
Semenzato, L, Botton, J, Drouin, J, et al. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health Eur. 2021;100158.CrossRefGoogle Scholar
Gemmati, D, Bramanti, B, Serino, ML, et al. COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? Int J Mol Sci. 2020;21(10):3474.CrossRefGoogle Scholar
Vaduganathan, M, Vardeny, O, Michel, T, et al. Reninangiotensin- aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653-1659.CrossRefGoogle Scholar
Gurwitz, D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020;81(5):537-540.Google ScholarPubMed
Leng, J, Goldstein, DR. Impact of aging on viral infections. Microbes Infect. 2010;12(14-15):1120-1124.Google ScholarPubMed
Lavan, AH, Gallagher, P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7(1):11-22.CrossRefGoogle ScholarPubMed
Iaccarino, G, Grassi, G, Borghi, C, et al. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension. Hypertension. 2020;76(2):366-372.Google ScholarPubMed
Djaharuddin, I, Munawwarah, S, Nurulita, A, et al. Comorbidities and mortality in COVID-19 patients. Gac Sanit. 2021;35:S530-S532. doi: 10.1016/j.gaceta.2021.10.085 CrossRefGoogle ScholarPubMed
Guan, W-j, Liang, W-h, Zhao, Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020. doı:10.1183/13993003.00547-2020CrossRefGoogle Scholar
Karyono, DR, Wicaksana, AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. J Community Empower Health. 2020;3(2):77.CrossRefGoogle Scholar
Sabaz, MS, Sabaz, S. Association of Charlson Comorbidity and Pneumonia Severity Indices with mortality in patients with coronavirus disease-2019 in the ıntensive care unit. Turk J Intensive Care. 2021;19:33-41. doi: 10.4274/tybd.galenos.2021.87587 Google Scholar
Özdemir, S. Evaluation of the relationship between demographic and clinical characteristics of hospitalized patients for COVID-19 and prognosis (COVID-19 Nedeniyle Yatırılarak Tedavi Edilen Hastaların Demografik ve Klinik Özelliklerinin Prognoz İle İlişkisinin Değerlendirilmesi). (Doctoral thesis, T.C. Ministry of Health Recep Tayyip Erdoğan University). 2021.CrossRefGoogle Scholar
Tuty Kuswardhani, RA, Henrina, J, Pranata, R, et al. Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(6):2103-2109.CrossRefGoogle Scholar